Literature DB >> 3465028

Advances in the understanding of the mechanism of cytoprotective action by colloidal bismuth subcitrate.

S J Konturek, T Radecki, I Piastucki, D Drozdowicz.   

Abstract

This study was designed to compare the gastroprotective effects of colloidal bismuth subcitrate (CBS) with those of sucralfate and methylated analog of prostaglandin E2 (PGE2) against acute gastric lesions induced by absolute ethanol, acidified aspirin (ASA), and water immersion and restraint stress in rats. When given orally, both CBS and sucralfate prevented in a dose-dependent way the formation of gastric lesions induced by all three ulcerogens, CBS being about 7, 2, and 20 times more potent, respectively on a weight-to-weight basis than sucralfate. Methylated PGE2 was also highly effective against these ulcerogens. Bismuth subnitrate was ineffective against acute gastric lesions induced by stress conditions. The protection of both CBS and sucralfate was reversible when the animals were pretreated with indomethacin to suppress the generation of endogenous prostaglandins. Since CBS and sucralfate increased the production of PGE2 in the gastric mucosa, we postulate that their gastric protective action may be mediated, at least partly, by mucosal prostaglandins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3465028     DOI: 10.3109/00365528609102578

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  11 in total

1.  Effect of bismuth subcitrate and sucralfate on rat duodenal and human gastric bicarbonate secretion in vivo.

Authors:  C J Shorrock; A Garner; A H Hunter; J R Crampton; W D Rees
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

2.  Effect of bismuth subcitrate on amphibian gastroduodenal bicarbonate secretion.

Authors:  C J Shorrock; J R Crampton; L C Gibbons; W D Rees
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

3.  Mechanism of action of nonantisecretory agents.

Authors:  J De Wal
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

Review 4.  Helicobacter pylori: bridging the credibility gap.

Authors:  A W McKinlay; R Upadhyay; C G Gemmell; R I Russell
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

Review 5.  Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.

Authors:  A J Wagstaff; P Benfield; J P Monk
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

6.  Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases.

Authors:  P E Coudron; C W Stratton
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

7.  Colloidal bismuth subcitrate-induced changes on gastric mucosal hemodynamics in the rat: gastric mucosal blood flow after CBS treatment.

Authors:  E Eleftheriadis; K Kotzampassi; E Tzartinoglou; A Salem; H Aletras
Journal:  Gastroenterol Jpn       Date:  1991-06

8.  Effect of Helicobacter pylori infection on colloidal bismuth subcitrate concentration in gastric mucus.

Authors:  D J Muñoz; C Tasman-Jones; J Pybus
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

9.  Bismuth subsalicylate in the treatment of H2 blocker resistant duodenal ulcers: role of Helicobacter pylori.

Authors:  S Wagner; M Gebel; K Haruma; W Bär; P Lange; J Freise; U Gladziwa; F W Schmidt
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

10.  De-Nol stimulates gastric and duodenal alkaline secretion through prostaglandin dependent mechanism.

Authors:  S J Konturek; J Bilski; N Kwiecien; W Obtuløwicz; B Kopp; J Oleksy
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.